Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.75 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.75 |
| ▸ | TYR | P14679 | 1/20 | 0.70 |
| ▸ | NFKB1 | P19838 | 3/20 | 0.69 |
| ▸ | CA1 | P00915 | 1/20 | 0.69 |
| ▸ | CA2 | P00918 | 1/20 | 0.69 |
| ▸ | CA4 | P22748 | 1/20 | 0.69 |
| ▸ | BCHE | P06276 | 3/20 | 0.68 |
| ▸ | GUSB | P08236 | 1/20 | 0.68 |
| ▸ | JUN | P05412 | 1/20 | 0.66 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.66 |
| ▸ | CHRNA7 | P36544 | 3/20 | 0.62 |
| ▸ | LMNA | P02545 | 3/20 | 0.61 |
| ▸ | MAOB | P27338 | 2/20 | 0.60 |
| ▸ | RAB9A | P51151 | 2/20 | 0.60 |
| ▸ | PLIN1 | O60240 | 1/20 | 0.60 |
| ▸ | TNFRSF1A | P19438 | 1/20 | 0.60 |
| ▸ | ACHE | P22303 | 1/20 | 0.60 |
| ▸ | RECQL | P46063 | 1/20 | 0.60 |
| ▸ | PLIN5 | Q00G26 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL626785 | 1.00 | MAPT (0.75) | MAPTMAPK1TYRNFKB1CA1 | |
| SCHEMBL29420130 | 1.00 | MAPT (0.75) | MAPTMAPK1TYRNFKB1CA1 | |
| SCHEMBL10893208 | 1.00 | MAPT (0.75) | MAPTMAPK1TYRNFKB1CA1 | |
| Methane SCHEMBL728022 | 0.98 | MAPT (0.73) | MAPTMAPK1TYRNFKB1CA1 | |
| Chalcone SCHEMBL28301237 | 0.93 | CYP1B1 (0.73) | MAPTMAPK1TYRNFKB1CA1 | |
| SCHEMBL21647113 | 0.90 | MAPT (0.71) | MAPTMAPK1TYRNFKB1CA1 | |
| SCHEMBL9250766 | 0.89 | MAPT (0.76) | MAPTMAPK1TYRNFKB1CA1 | |
| SCHEMBL5576960 | 0.89 | MAPT (0.76) | MAPTMAPK1TYRNFKB1CA1 | |
| SCHEMBL9006476 | 0.88 | MAPT (0.69) | MAPTMAPK1TYRNFKB1BCHE | |
| SCHEMBL30872967 | 0.87 | IAPP (0.62) | MAPTMAPK1TYRNFKB1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 953 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122005538-A | Application of flavonoid compounds in treating cerebral small vessel diseases | 南通大学 | 2026-05-12 | — | — | CN | claimed |
| US-20260096569-A1 | EDIBLE COATING WITH ANTIMICROBIAL PROPERTIES | APEEL TECH INC (US) | 2026-04-09 | — | — | US | claimed |
| EP-4462543-B1 | AN ELECTROLYTE ADDITIVE AND A PREPARATION METHOD THEREFOR, AN ELECTROLYTE AND A LITHIUM ION BATTERY | JIANGSU ZENERGY BATTERY TECH GROUP CO LTD (CN) | 2026-01-21 | — | — | EP | claimed |
| CN-119823729-A | Composition for preparing cooling liquid, preparation method and application thereof | 张家港迪克汽车化学品有限公司 | 2025-04-15 | — | — | CN | claimed |
| EP-4496476-A1 | GAS PHASE TREATMENT OF PRODUCE | Apeel Technology, Inc. (US) | 2025-01-29 | — | — | EP | claimed |
| CN-119185267-A | Application of 2-Hydroxychalcone in preparation of anti-inflammatory drugs | 西南医科大学附属医院 | 2024-12-27 | — | — | CN | claimed |
| CN-119156138-A | Vapor treatment of agricultural products | 阿比尔技术公司 | 2024-12-17 | — | — | CN | claimed |
| EP-4462543-A1 | AN ELECTROLYTE ADDITIVE AND A PREPARATION METHOD THEREFOR, AN ELECTROLYTE AND A LITHIUM ION BATTERY | Jiangsu Zenergy Battery Technologies Co., Ltd. (CN) | 2024-11-13 | — | — | EP | claimed |
| US-20240368070-A1 | Electrolyte Additive and a Preparation Method Therefor, an Electrolyte and a Lithium Ion Battery | Jiangsu Zenergy Battery Technologies Co., Ltd. (CN) | 2024-11-07 | — | — | US | claimed |
| CN-118852179-A | Synthesis method of chiral trifluoromethyl-containing pyrrolidine spiro-oxindole compound | 河南师范大学 | 2024-10-29 | — | — | CN | claimed |
| CN-1095590-A | By parasite or bacterial treatment of diseases and prevention | STATENS SERUMINSTITUT (DK) | 1994-11-30 | — | — | CN | claimed |
| EP-0528975-A4 | GROWTH INHIBITORS AND METHODS OF TREATING CANCER AND CELL PROLIFERATIVE DISEASES | — | 1993-09-15 | — | — | EP | claimed |
| EP-0528975-A1 | GROWTH INHIBITORS AND METHODS OF TREATING CANCER AND CELL PROLIFERATIVE DISEASES | BAYLOR COLLEGE OF MEDICINE (US) | 1993-03-03 | — | — | EP | claimed |
| WO-1991017749-A1 | GROWTH INHIBITORS AND METHODS OF TREATING CANCER AND CELL PROLIFERATIVE DISEASES | BAYLOR COLLEGE OF MEDICINE (US) | 1991-11-28 | — | — | WO | claimed |
| US-5068364-A | Antiulcer agents, antiallergens | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1991-11-26 | — | — | US | claimed |
| EP-0370461-A2 | Chalcone derivatives and process for producing the same | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1990-05-30 | — | — | EP | claimed |
| EP-0173748-B1 | PROCESS FOR PRODUCING SUBSTITUTED UNSATURATED SIX-MEMBERED RING COMPOUNDS FROM PHENOL DERIVATIVES | HIRAI, Hidefumi (JP) | 1990-01-03 | — | — | EP | claimed |
| US-4867964-A | SUNSCREEN | L'OREAL (FR) | 1989-09-19 | — | — | US | claimed |
| US-4663478-A | Process for producing a para-substituted phenol derivative | Hirai, Hidefuni | 1987-05-05 | — | — | US | claimed |
| EP-0173748-A1 | PROCESS FOR PRODUCING SUBSTITUTED UNSATURATED SIX-MEMBERED RING COMPOUNDS FROM PHENOL DERIVATIVES | HIRAI, Hidefumi (JP) | 1986-03-12 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260096569-A1 | EDIBLE COATING WITH ANTIMICROBIAL PROPERTIES | CYP51A1, ERG28, NISCH | MAPT 4702/4885MAPK1 673/4885TYR 85/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.